How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
NVIDIA AI Podcast
00:00
Intro
This chapter explores how AI technology is revolutionizing drug development in the biopharmaceutical industry, focusing on Bristol-Myers Squibb's mission to integrate digital advancements. The discussion highlights the company's strategic vision for delivering innovative treatments by 2030 through the use of AI-driven methods.
Transcript
Play full episode
